MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension

Overview of attention for article published in Graefe's Archive for Clinical and Experimental Ophthalmology, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Study: MERCURY-3 trial results support efficacy of Roclanda

Ophthalmology Times, 16 Sep 2023

(Image Credit: AdobeStock) A study, citing results from the MERCURY-3 trial of latanoprost/netarsudil fixed-dose combination (Roc…

Study: MERCURY-3 trial results support efficacy of Roclanda

Ophthalmology Times Europe, 13 Sep 2023

According to Santen, study results from the MERCURY-3 trial of latanoprost/netarsudil support it as an alternative (FDC…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.